Bloomberg Intelligence's 'Equity Market Minute' 7/22/2021

The video discusses the impact of COVID-19 infections on global equity markets, highlighting the outperformance of U.S. stocks during rising infection rates. It examines the correlation between infection rates and stock performance, suggesting potential market rotations. The analysis includes a look at valuation multiples and earnings across regional markets, noting the high premium of U.S. stocks. The video concludes with insights on market trends and valuations.

How are U.S. stocks performing in relation to global equities amid rising COVID-19 infections?

• U.S. stocks are underperforming.

• U.S. stocks are outperforming.

• U.S. stocks are performing the same as global equities.

• U.S. stocks are not affected by COVID-19 infections.

What is the relationship between infection rates and U.S. stock performance?

• U.S. stocks perform better when infection rates fall.

• As infection rates rise, U.S. stocks outperform.

• As infection rates rise, U.S. stocks underperform.

• Infection rates have no impact on U.S. stock performance.

What might prevent the recent rotation in U.S. stocks from continuing?

• High valuations

• Increased government spending

• Low interest rates

• Strong global economic growth

How do U.S. stock valuations compare to their long-term average?

• They are 2.0 standard deviations above the long-term average.

• They are 1.6 standard deviations above the long-term average.

• They are at the long-term average.

• They are below the long-term average.

What premium do U.S. stocks command over global equities on average?

• 5%

• 10%

• 15%

• 20%